Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 USD | -0.15% | -7.55% | -21.69% |
May. 09 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, vs. Street Est of $8M | MT |
Business Summary
Number of employees: 30
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Prescription Drug Products
100.0
%
| 21 | 100.0 % | 32 | 100.0 % | +48.90% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 32 | 100.0 % | +48.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 17-05-31 |
James Gruber
DFI | Director of Finance/CFO | 52 | 22-04-10 |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Corporate Officer/Principal | - | - | |
Sales & Marketing | - | 18-07-31 | |
Ingrid Hoos
LAW | General Counsel | - | - |
David Krempa
PRN | Corporate Officer/Principal | 35 | 17-08-31 |
Kevin Guthrie
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-05-31 | |
Paul Maier
BRD | Director/Board Member | 76 | 17-09-13 |
Norbert Riedel
CHM | Chairman | 66 | 17-09-06 |
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 17-05-31 |
Jenn Adams
BRD | Director/Board Member | - | 21-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,688,062 | 24,338,695 ( 94.75 %) | 0 | 94.75 % |
Company contact information
Eton Pharmaceuticals, Inc.
21925 West Field Parkway Suite 235
60010-7278, Deer Park
+
http://www.etonpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.69% | 88.24M | |
+7.91% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+20.84% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B |
- Stock Market
- Equities
- ETON Stock
- Company Eton Pharmaceuticals, Inc.